title: Eculizumab for aHUS post-transplantation: when and how to stop a good thing.
authors: Regional Nephrology Unit, Belfast City Hospital, Belfast, Northern Ireland. amasengu@gmail.com.
authors: Agnes
authors: A
authors: Masengu
authors: Regional Nephrology Unit, Belfast City Hospital, Belfast, Northern Ireland.
authors: Aisling
authors: A
authors: Courtney
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D065766:Atypical Hemolytic Uremic Syndrome / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation; D012008:Recurrence; D028761:Withholding Treatment
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C481642:eculizumab